WuXi AppTec (OTCMKTS:WUXAY) Stock Price Up 2.1% – Still a Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) traded up 2.1% during mid-day trading on Thursday . The company traded as high as $14.26 and last traded at $14.1650. 1,785 shares traded hands during trading, a decline of 41% from the average session volume of 3,031 shares. The stock had previously closed at $13.87.

Analyst Ratings Changes

Separately, The Goldman Sachs Group raised WuXi AppTec to a “buy” rating in a research note on Thursday. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy”.

WuXi AppTec Stock Performance

The stock’s 50 day simple moving average is $13.69 and its two-hundred day simple moving average is $13.71.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.